Pharmacokinetics, Bioavailability, Excretion and Metabolism Studies of Akebia Saponin D in Rats: Causes of the Ultra-Low Oral Bioavailability and Metabolic Pathway
Background: Akebia saponin D (ASD) has a variety of biological activities and great medicinal potential, but its oral bioavailability is so low as to limit its development. Its pharmacokinetic profiles and excretion and metabolism in vivo have not been fully elucidated. This study was an attempt in...
Saved in:
Main Authors: | Pengfei Li (Author), Jun Peng (Author), Yuexin Li (Author), Lili Gong (Author), Yali Lv (Author), He Liu (Author), Tianhong Zhang (Author), Song Yang (Author), Hongchuan Liu (Author), Jinglai Li (Author), Lihong Liu (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2021-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pharmacokinetics, bioavailability, metabolism and excretion of δ-viniferin in rats
by: Ping Mao, et al.
Published: (2016) -
Protective Effects of Akebia Saponin D Against Rotenone-Induced Hepatic Mitochondria Dysfunction
by: Li-li Gong, et al.
Published: (2014) -
Akebia saponin D alleviates hepatic steatosis through BNip3 induced mitophagy
by: Li-li Gong, et al.
Published: (2018) -
Rilzabrutinib, a reversible covalent Bruton's tyrosine kinase inhibitor: Absorption, metabolism, excretion, and absolute bioavailability in healthy participants
by: Sibel Ucpinar, et al.
Published: (2023) -
Oral Bioavailability, Tissue Distribution, Metabolism, and Excretion of Panduratin A from Boesenbergia rotunda Extract in Healthy Rats
by: Kongratanapasert T, et al.
Published: (2024)